Medical Treatment of Opoid Use Disorder (OUD)

34
Medical Treatment of Opoid Use Disorder (OUD) Mike Bushey, MD, PhD Assistant Professor of Psychiatry Indiana University School of Medicine

Transcript of Medical Treatment of Opoid Use Disorder (OUD)

Page 1: Medical Treatment of Opoid Use Disorder (OUD)

Medical Treatment of Opoid Use

Disorder (OUD)Mike Bushey, MD, PhD

Assistant Professor of PsychiatryIndiana University School of Medicine

Page 2: Medical Treatment of Opoid Use Disorder (OUD)

PART 1: DEFINING & DIAGNOSING ADDICTION

Page 3: Medical Treatment of Opoid Use Disorder (OUD)

ADDICTION leads to PERMANENT BRAIN CHANGES that ALTER BEHAVIOR

Page 4: Medical Treatment of Opoid Use Disorder (OUD)

Behavior Can Be DRIVEN

4

THIRST DRINKHUNGER EATEXHAUSTION SLEEP

Page 5: Medical Treatment of Opoid Use Disorder (OUD)

Hun

ger

Time

Page 6: Medical Treatment of Opoid Use Disorder (OUD)

Hun

ger

Time

Choice to Eat

Page 7: Medical Treatment of Opoid Use Disorder (OUD)

Hun

ger

Time

Choice to Eat

Page 8: Medical Treatment of Opoid Use Disorder (OUD)

Hun

ger

Time

Choice to Eat

Page 9: Medical Treatment of Opoid Use Disorder (OUD)

Behavior Can Be LEARNED

BEHAVIOR CONSEQUENCE

Page 10: Medical Treatment of Opoid Use Disorder (OUD)

BEHAVIOR PUNISHMENT-

Page 11: Medical Treatment of Opoid Use Disorder (OUD)

+BEHAVIOR REWARD

Page 12: Medical Treatment of Opoid Use Disorder (OUD)

USE OPIOID CONSEQUENCE

Page 13: Medical Treatment of Opoid Use Disorder (OUD)

USE OPIOID NAUSEA-

Page 14: Medical Treatment of Opoid Use Disorder (OUD)

USE OPIOID EUPHORIA

+

Page 15: Medical Treatment of Opoid Use Disorder (OUD)

USE OPIOIDS

Feel BetterWithdrawal(Craving)

Mood

Euphoria

Time

Page 16: Medical Treatment of Opoid Use Disorder (OUD)

Behavior Can Be DRIVEN

16

THIRST DRINKHUNGER EATEXHAUSTION SLEEP

CRAVING USE OPIOIDS

INNATE

DISEASE

Page 17: Medical Treatment of Opoid Use Disorder (OUD)

DSM-V Criteria for Opioid Use Disorder (OUD)1. Larger amounts or over a longer period than intended.2. Unsuccessful efforts to cut down or control opioid use.3. Great deal of time is spent to obtain, use or recover from opioids.4. Cravings for opioids.5. Failure to fulfill roles at work, school, or home.6. Social or interpersonal problems caused by opioids.7. Activities are given up or reduced because of opioid use.8. Physically hazardous opioid use9. Continued opioid use despite physical or psychological consequences10. Tolerance.*11. Withdrawal.*

For Diagnosis of OUD:Mild: 2-3 presentModerate: 4-5 presentSevere: 6 or more present

* Don’t count toward OUD diagnosis if patient is prescribed opioids

Page 18: Medical Treatment of Opoid Use Disorder (OUD)

DSM-V Criteria for Opioid Use Disorder (OUD)

1. Larger amounts or over a longer period than intended.2. Unsuccessful efforts to cut down or control opioid use.3. Great deal of time is spent to obtain, use or recover from opioids.4. Cravings for opioids.5. Failure to fulfill roles at work, school, or home.6. Social or interpersonal problems caused by opioids.7. Activities are given up or reduced because of opioid use.8. Physically hazardous opioid use9. Continued opioid use despite physical or psychological consequences10. Tolerance.*11. Withdrawal.*

Impaired Control Over Use

Social ConsequencesHealth Consequences

Physiologic Dependence

Page 19: Medical Treatment of Opoid Use Disorder (OUD)

PART 2: TREATING ADDICTION

Page 20: Medical Treatment of Opoid Use Disorder (OUD)

TREATMENT GOAL:DECREASE the ODDSthe ADDICTED BRAIN will CHOOSE the ADDICTED BEHAVIOR.

Page 21: Medical Treatment of Opoid Use Disorder (OUD)

Addiction Treatment

NIDA. Principles of Drug Addiction Treatment. 2012. McLellan et al., JAMA, 284:1689-1695, 2000 .

Hypertension Treatment Addiction Treatment

Page 22: Medical Treatment of Opoid Use Disorder (OUD)

Treatment Modalities for SUDs

Pharmacotherapy• Alcohol use disorder

naltrexone, acamprosate, disulfiram, topiramate

• Opioid use disorder methadone, buprenorphine, naltrexone

• Tobacco use disorder varenicline, bupropion, NRT

• Cocaine use disorder• Topiramate, naltrexone

• Methamphetamine use disorder• Bupropion/naltrexone

Psychosocial/behavioral• Modalities Cognitive Behavioral Therapy (CBT) Motivational Enhancement Therapy (MET)

Page 23: Medical Treatment of Opoid Use Disorder (OUD)

Treatment Modalities for SUDs

Pharmacotherapy• Alcohol use disorder

naltrexone, acamprosate, disulfiram, topiramate

• Opioid use disorder methadone, buprenorphine, naltrexone

• Tobacco use disorder varenicline, bupropion, NRT

• Cocaine use disorder• Topiramate, naltrexone

• Methamphetamine use disorder• Bupropion/naltrexone

Psychosocial/behavioral• Modalities Cognitive Behavioral Therapy (CBT) Motivational Enhancement Therapy (MET)

Page 24: Medical Treatment of Opoid Use Disorder (OUD)

Readiness for Change

Precontemplation

Contemplation

Action

Maintenance Preparation

Relapse

Page 25: Medical Treatment of Opoid Use Disorder (OUD)

Medication for Opioid Use Disorder (MOUD)

• Improves patient survival• Increases retention in treatment• Decreases illicit opioid use• Decreases criminal activity• Increase patients’ ability to gain and maintain employment• Improves birth outcomes among pregnant women• Lowers a person’s risk of contracting HIV or hepatitis C

Substance Abuse & Mental Health Services Agency, 2020

Page 26: Medical Treatment of Opoid Use Disorder (OUD)

Opioid

OpioidReceptor

Page 27: Medical Treatment of Opoid Use Disorder (OUD)

Opioid

OpioidReceptor

Page 28: Medical Treatment of Opoid Use Disorder (OUD)

FULL AGONIST (Methadone)

Page 29: Medical Treatment of Opoid Use Disorder (OUD)

FULL AGONIST (Methadone)

PARTIAL AGONIST(Buprenorphine)

Page 30: Medical Treatment of Opoid Use Disorder (OUD)

ANTAGONIST(Naltrexone)

FULL AGONIST (Methadone)

PARTIAL AGONIST(Buprenorphine)

Page 31: Medical Treatment of Opoid Use Disorder (OUD)

Opi

oid

Effe

ct

Dose

PARTIAL AGONIST(Buprenorphine)

FULL AGONIST (Methadone)

ANTAGONIST(Naltrexone)

Page 32: Medical Treatment of Opoid Use Disorder (OUD)

MOUDisVeryEffective in Treatment Retention

Kakko, et al. The Lancet 361, no. 9358 (2003): 662-68.

Page 33: Medical Treatment of Opoid Use Disorder (OUD)

MOUD Benefits Are Consistent Across Studies

Haight, et al. The Lancet 393, no. 10173 (2019): 778-90.

Page 34: Medical Treatment of Opoid Use Disorder (OUD)

MOUD Also CanIncrease Abstinence

Haight, et al. The Lancet 393, no. 10173 (2019): 778-90.